STOCKHOLM, April 13, 2016 – Elekta’s (EKTA-B.ST) Board of Directors has
appointed Richard Hausmann, to lead the company effective June 10, 2016. He will
succeed Tomas Puusepp, current President and Chief Executive Officer.
Laurent Leksell, Elekta’s founder and Chairman of the Board of Directors, says:
“Richard Hausmann joins us with nearly three decades of experience in the
medical device industry. He led GE’s Magnetic Resonance (MR) division as
President and CEO, served as President and CEO of Siemens computed tomography
(CT) and worked at Siemens in leading positions in its MR business. He also
acted as CEO of Siemens China, responsible for the company’s entire portfolio in
its core emerging market. Richard has a solid track record of bringing clinical
innovations to the global health care market and is known for his deep insights
into customer and patient needs, with a strong outcome orientation.”
He adds: “The board is grateful to Tomas Puusepp, who reassumed the position as
Elekta President and CEO in May 2015. He will continue as a working board member
for Elekta from June 10.”
Richard Hausmann says: “I very much look forward to joining Elekta and the
opportunity to contribute to its remarkable track record as the leading
innovator in radiation oncology and neurosurgery. I am excited about Elekta, a
customer and patient focused company, and its offering of advanced clinical
solutions.”
Hausmann has a doctorate in physics from the University of Regensburg.
Richard Hausmann will join May 1, 2016 and take over as President and CEO on
June 10. His CV and photos are attached to this press release.
# # #
For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Tobias Bülow, Director Financial Communication, Elekta AB
Tel: +46 722 215 017, e-mail: tobias.bulow@elekta.com
Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 07:30 CET on April 13, 2016.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,800 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on NASDAQ Stockholm. Website: www.elekta.com.
